Laronidase replacement therapy and left ventricular function in mucopolysaccharidosis I

JIMD Reports

Volumn 16, Issue , 2014, Pages 39-45

  Harada, Haruhito ^a   Niiyama, Hiroshi ^a   Katoh, Atsushi ^a   Ikeda, Hisao ^a  

^a KURUME UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Diastolic function; Left ventricular contraction; Left ventricular diastolic function; Speckle tracking echocardiography; Spleen volume

Indexed keywords

EID: 84976305758     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2014_316     Document Type: Chapter

References (26)

1. Arora RS, Mercer J, Thornley M, Tylee K, Wraith JE (2007) Enzyme replacement therapy in 12 patients with MPS I-H/S with homozygous p.Leu490Pro mutation. J Inherit Metab Dis 30:821
2. Beaver TA, Steiner J, Sullivan CD, Costa SP, Palac RT (2011) Two-dimensional longitudinal strain in patients with aortic stenosis can be reliably acquired at the bedside without additional benefit of offline analysis. Echocardiography 28:22–28
3. Braunlin EA, Berry JM, Whitley CB (2006) Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I. Am J Cardiol 98:416–418
4. Braunlin EA, Harmatz PR, Scarpa M et al (2011) Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management. J Inherit Metab Dis 34:1183–1197
5. Brown MB, Trivette PS (1998) Mucopolysaccharide disorders. In: Phelps L (ed) Health-related disorders in children and adolescents: a guidebook for understanding and educating. American Psychological Association, Washington DC, pp 442–452
6. Dekaban AS, Constantopoulos G, Herman MM, Steusing JK (1976) Mucopolysaccharidosis type V. (Scheie syndrome). A postmortem study by multidisciplinary techniques with emphasis on the brain. Arch Pathol Lab Med 100:237–245
7. D’hooge J, Heimdal A, Jamal F et al (2000) Regional strain and strain rate measurement by cardiac ultrasound: principles, implication and limitations. Eur J Echocardiogr 1:154–170
8. Harada H, Uchiwa H, Nakamura M et al (2011) Laronidase replacement therapy improves myocardial function in mucopolysaccharidosis I. Mol Genet Metab 103:215–219
9. Hurlburt HM, Aurigemma GP, Hill JC et al (2007) Direct ultrasound measurement of longitudinal, circumferencial, and radial strain using 2-dimensional strain imaging in normal adults. Echocardiography 24:723–731
10. Jordanb MC, Zhenga Y, Ryazantseva S, Rozengurtc N, Roosb KP, Neufelda EF (2005) Cardiac manifestations in the mouse model of mucopolysaccharidosis I. Mol Genet Metab 86:233–243
11. Kakkis ED, Muenzer J, Tiller GE et al (2001) Enzyme replacement therapy in mucopolysaccharidosis I. N Engl J Med 344:182–188
12. Leite-Moreira AF (2006) Current perspectives in diastolic dysfunction and diastolic heart failure. Heart 92:712–718
13. McKusick VA, Kaplan D, Wise D et al (1965) The genetic mucopolysaccharidosis. Medicine 44:445–483
14. Nagashima K, Endo H, Sakakibara K et al (1976) Morphological and biochemical studies of a case of mucopolysaccharidosis II (Hunter’s syndrome). Acta Pathol Jpn 26:115–132
15. Neufeld EF, Muenzer J (2001) The mucopolysaccharidosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw Hill, New York, pp 3421–3452
16. Notomi Y, Setser RM, Shiota T et al (2005) Assessment of left ventricular torsional deformation by Doppler tissue imaging. Validation study with tagged magnetic resonance imaging. Circulation 111:1141–1147
17. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ (2003) Burden of systolic and diastolic ventricular dysfunction in the community. Appreciating the scope of the heart failure epidemic. J Am Med Assoc 289:194–202
18. Scott HS, Guo XH, Hopwood JJ, Morris CP (1992) Structure and sequence of the human alpha-L-iduronidase gene. Genomics 13:1311–1313
19. Shimamura K, Hakozaki H, Takahashi K et al (1976) Sanfilippo B syndrome. A case report. Acta Pathol Jpn 26:739–764
20. Shull RM, Kakkis ED, McEntee MF, Kania SA, Jonas AJ, Neufeld EF (1994) Enzyme replacement in a canine model of Hurluer syndrome. Proc Natl Acad Sci U S A 91:12937–12941
21. Sifuentes M, Doroshow R, Hoft R et al (2007) A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years. Mol Genet Metab 90:171–180
22. Sohn DW, Chai IH, Lee DJ et al (1997) Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 30:474–480
23. Soliman OII, Timmermans RGM, Nemes A et al (2007) Cardiac abnormalities in adults with the attenuated form of mucopolysaccharidosis type I. J Inherit Metab Dis 30:750–757
24. Voigt JU, Flachskampf FA (2004) Strain and strain rate. New and clinically relevant echo parameters of regional myocardial function. Z Kardiol 93:249–258
25. Wraith JE (2001) Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties. J Inherit Metab Dis 24:245–250
26. Wraith JE, Clarke LA, Beck M et al (2004) Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase). J Pediatr 144:581–588